Application of FDG-PET/CT in Radiation Oncology
Open Access
- 1 January 2013
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 3, 80
- https://doi.org/10.3389/fonc.2013.00080
Abstract
Positron emission tomography (PET)/computed tomography (CT), which combines the advantages of high sensitivity and specificity of PET and high resolution of CT, is a unique tool for cancer management. PET/CT has been widely used in cancer diagnosis and treatment. The article reviews the recent applications of PET/CT in radiation oncology, with a focus on FDG-PET/CT, addressing the applications in treatment planning and treatment response assessment of radiation therapy.Keywords
This publication has 67 references indexed in Scilit:
- Assessment of tumour size in PET/CT lung cancer studies: PET- and CT-based methods compared to pathologyEJNMMI Research, 2012
- The Role of Fluorine-18-fluorodeoxyglucose Positron Emission Tomography in Assessing the Response to Neoadjuvant Treatment in Patients with OsteosarcomaInternational Journal of Molecular Imaging, 2012
- Review of functional/anatomical imaging in oncologyNuclear Medicine Communications, 2012
- Dose-escalation using intensity-modulated radiotherapy for prostate cancer - evaluation of quality of life with and without 18F-choline PET-CT detected simultaneous integrated boostRadiation Oncology, 2012
- Current concepts in F18 FDG PET/CT-based radiation therapy planning for lung cancerFrontiers in Oncology, 2012
- Early CT and FDG-metabolic tumour volume changes show a significant correlation with survival in stage I–III small cell lung cancer: A hypothesis generating studyRadiotherapy and Oncology, 2011
- Development and external validation of a predictive model for pathological complete response of rectal cancer patients including sequential PET-CT imagingRadiotherapy and Oncology, 2010
- Evaluation of gross tumor size using CT, 18F-FDG PET, integrated 18F-FDG PET/CT and pathological analysis in non-small cell lung cancerEuropean Journal of Radiology, 2009
- Metabolic control probability in tumour subvolumes or how to guide tumour dose redistribution in non-small cell lung cancer (NSCLC): An exploratory clinical studyRadiotherapy and Oncology, 2009
- Standardised FDG uptake: A prognostic factor for inoperable non-small cell lung cancerEuropean Journal Of Cancer, 2005